The application discloses application of a compound containing a condensed heterocyclic structure in preparation of a
medicine for preventing or treating gastric ulcer, and relates to the technical field of
medicinal chemistry. It is found through a large amount of screening and
verification that the compounds 8018-9590, G642-6944, L861-0480 and E844-1779 can significantly reduce ulcer foci, significantly reduce the degree of hemorrhage, and specifically reduce mucosal
edema and other core
pathological characteristics of gastric ulcer, and the ulcer inhibition rate reaches 50.00%. The application provides a new compound type for screening of a
medicine for treating gastric ulcer, and provides an important candidate for development of a new anti-ulcer
medicine.